Inventiva (IVA) Depreciation & Amortization (CF) (2019 - 2025)

Inventiva's (IVA) quarterly Depreciation & Amortization (CF) came in at -$19.0 million in Q2 2025, down 42.54% year-on-year from -$33.1 million in Q2 2024, and down 17.2% quarter-over-quarter from -$16.2 million in Q4 2024.

Inventiva (IVA) Depreciation & Amortization (CF) (2019 - 2025) Analysis & Trends

Inventiva's Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at -$19.0 million for Q2 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 42.54% year-over-year to -$19.0 million in Q2 2025; TTM through Dec 2025 was $1.3 million, a 108.07% increase from a year earlier, with the FY2024 full-year figure at -$16.2 million, down 40.84% from the prior year.
  • Depreciation & Amortization (CF) slipped to -$19.0 million in Q2 2025 per IVA's latest filing, from -$16.2 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $662584.1 in Q3 2022 and bottomed at -$19.0 million in Q2 2025.
  • The 5-year median for Depreciation & Amortization (CF) is -$5.0 million (2021), against an average of -$6.8 million.
  • Across the five-year window, Depreciation & Amortization (CF) grew 6.05% in 2022 and slumped 1879.35% in 2023, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $610880.5 in 2021, then rose by 6.05% to $647857.1 in 2022, then slumped by 1879.35% to -$11.5 million in 2023, then tumbled by 40.84% to -$16.2 million in 2024, then dropped by 17.2% to -$19.0 million in 2025.
  • Per Business Quant, the three latest IVA Depreciation & Amortization (CF) figures stand at -$19.0 million (Q2 2025), -$16.2 million (Q4 2024), and -$13.3 million (Q2 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 41.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - 91,781.47
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Inventiva 842.48 Mn 842.48 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -19.03 Mn
Jun 30, 2025 -19.03 Mn
Dec 31, 2024 -16.24 Mn
Dec 31, 2024 -16.24 Mn
Jun 30, 2024 -13.35 Mn
Jun 30, 2024 -13.35 Mn
Dec 31, 2023 -11.53 Mn
Dec 31, 2023 -11.53 Mn
Jun 30, 2023 -10.33 Mn
Jun 30, 2023 -10.33 Mn
Dec 31, 2022 647,857.08
Dec 31, 2022 647,857.08
Sep 22, 2022 662,584.15
Sep 22, 2022 662,584.15
Dec 31, 2021 610,880.49
Dec 31, 2021 610,880.49
Jun 30, 2021 276,982.43
Jun 30, 2021 276,982.43
Mar 31, 2021 366,695.78
Mar 31, 2021 366,695.78